In the second part of his Pharma Commerce video interview, Franco Stevanato, CEO of Stevanato Group, describes how from FDA ...
The pharmaceutical industry relies heavily on its supply chain, but this chain can also have a significant environmental impact due to common factors like high emissions or packaging waste.
The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...
Global Pharmaceutical Manufacturing Equipment Market OverviewThe global pharmaceutical manufacturing equipment market is on a growth trajectory, projected to expand at a CAGR of 6–8% over the forecast ...
MAPLE GROVE, Minn., Dec. 9, 2025 /PRNewswire/ -- Bora Pharmaceuticals Co., Ltd. ("Bora", TWSE: 6472), a global leader in pharmaceutical manufacturing, and Corealis ...
Low compliance by the country’s 8,500 small and medium enterprises (MSMEs) manufacturing pharmaceuticals would raise the risk ...
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
Strengthens service portfolio to meet growing demand for early-phase clinical trial support and innovation CRYSTAL LAKE, Ill.--(BUSINESS WIRE)-- Aptar Pharma, a global leader in drug delivery and ...
The "Fill Finish Manufacturing Market - A Global and Regional Analysis: Focus on Product, End Users, and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering.
Roughly a year after receiving an FDA reprimand at its manufacturing plant in Michigan, Indian drugmaker Piramal Pharma has landed in the regulator’s crosshairs once again. Following an inspection of ...
The global Pharmaceutical Isolator market was valued at USD 432 Million in the year 2024 and is projected to reach a revised size of USD 509 Million by 2031, growing at a CAGR of 2.4% during the ...
Hosted on MSN
Strategic quality leadership: Niraj Patel’s transformative roles in pharmaceutical excellence
The competitive environment in the pharmaceutical industry is characterized by the insatiable innovation push that is supported by the strict quality requirements and regulatory adherence. This ...
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announces its acquisition of the clinical trial materials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback